Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
about
Molecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the PicovirinaeBacteriophage Procurement for Therapeutic PurposesInsights into Bacteriophage Application in Controlling Vibrio SpeciesAntibiotic alternatives: the substitution of antibiotics in animal husbandry?Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureusApplication of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care UnitCombined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.The search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae.Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite DecontaminantThe isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity.The role of regulated clinical trials in the development of bacteriophage therapeutics.Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestineBacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive PathogensT4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickensImmunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.Biofilm infections, their resilience to therapy and innovative treatment strategies.Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.Strategies for combating bacterial biofilm infections.Bacteriophage therapy against Enterobacteriaceae.Biofilm control with natural and genetically-modified phages.Phage Therapy: Future Inquiries.Phage Therapy in the Era of Synthetic Biology.Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates.Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates.Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms.Current Research Approaches to Target Biofilm Infections.Multiple-site mutations of phage Bp7 endolysin improves its activities against target bacteria.Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)On the interactions between virulent bacteriophages and bacteria in the gut.Bacteriophage therapy for membrane biofouling in membrane bioreactors and antibiotic-resistant bacterial biofilms.Can phage effectively treat multidrug-resistant plague?Investigations on the interactions of λphage-derived peptides against the SrtA mechanism in Bacillus anthracis.Complete Genome Sequence of the Siphoviral Bacteriophage Ec-ZZ2, Which Is Capable of Lysing Enterococcus faeciumWound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds.Isolation and characterization of phages with lytic activity against methicillin-resistant Staphylococcus aureus strains belonging to clonal complex 398.Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms.
P2860
Q21134546-4E48972C-2C14-4EB4-8E22-D0201A688E41Q26738479-DD63B6F1-B78F-4C21-9F02-5486F7C3A894Q26739744-C62F91F9-7C0D-4ACA-BFF8-8F82E01B0788Q27027984-1EF7E52A-51CC-4BA7-92E7-E9DEDEBEF60AQ28485429-6C077B65-54D3-4C4A-BD8D-D79CA3F1A9EBQ28555082-2CE87C8C-CAF1-4B09-8C44-1FCD6D4E3CD7Q34594381-7BE911E1-050B-4A5F-8147-C1CD397A8976Q35023371-AE8A3874-7828-4B9F-82FA-335CA860670FQ35679714-69ED9CAF-C47A-46F9-B55E-0CA1D362D2CCQ35763512-8FFC00CA-184F-426C-81D2-ABA00FA755EBQ36135134-5A83FB87-E17C-493C-B3E2-F55FFFC65334Q36396212-F03E0B18-CA54-4797-BC49-6EE8C686BB17Q36933039-5F8E41FD-1BA4-4745-BAEF-DAC9E56DF4B7Q37106265-5F79D7A0-87B6-490A-A441-E1CBA2C0DA00Q37123678-F71DA80D-6024-469C-BF7B-C892A28B4296Q37991389-03A6D049-5743-4356-9A80-BA42BF07D6C1Q38017216-922C7067-B5AE-405A-AE09-047B66311C3CQ38048367-55823E0E-4CA1-4AC2-863D-9C8AFFE6BA78Q38120559-4137272C-7F8A-4ADC-B8AD-71BFEED5BFC6Q38215724-36142F84-56EA-4561-BA11-F2661A178798Q38287542-464A8E2F-5AEB-48C6-8E4E-B48724767BBDQ38348303-A0410481-A346-411D-A413-E34313F63E48Q38756810-A33E0022-75E5-490D-9BCF-FE24B75F46D3Q38911928-0DA3BBFF-C4F3-4412-A28B-6DB4C6107F3AQ38915649-C7444610-7D37-453D-8865-89D7797B27EDQ39908459-7E5F9EB7-3B04-4338-92AB-9F801935FD52Q40058358-37246601-18D3-4855-998C-221F5C23A3A2Q40421266-312E5406-A0D8-4E82-A989-00CCEB043E2AQ40602967-FBA3EBEC-7EEC-4281-9155-45529D65F638Q41106529-0E8FEF79-0941-4810-BF50-55B5B4344775Q41195662-80DBB685-A4F0-41A8-8108-19D2376700F2Q41295826-07CF9453-EC30-425C-AFCB-130C73D246F9Q41300944-C028F978-2EB7-4621-9094-BB9CEE7D3D28Q41329193-3E03D6B8-FB4A-4DE9-896F-7C685B2FF58CQ41402927-D01A15E0-F039-4CD6-B1DF-86456B90F3E8Q42253860-0DAF3EF2-C56D-49F3-A90F-0494A5F316D2Q42366437-C5C98AD4-71AE-4080-A782-84F86EC785DDQ43700519-BF7A73D8-FAD7-452E-B872-9FAC570094CCQ44235449-348BAC64-A2B0-4D2A-9CBB-5C2D27B1FE31Q49829450-0129FC08-ED1B-4086-B3AD-70A9402607F3
P2860
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@en
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@nl
type
label
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@en
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@nl
prefLabel
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@en
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@nl
P2093
P2860
P356
P1476
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
@en
P2093
Ben Burrowes
David R Harper
Joseph Anderson
Malcolm McConville
P2860
P304
P356
10.1586/ERI.11.90
P50
P577
2011-09-01T00:00:00Z